Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linker

Showing results (481-490 of 860) with videos related to

Pageof 86
Sort By:
Frontiers in Neurology|August 6, 2021
Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander?Andrea Wagner, Jonas Maderer, Sibylle Wilfling, et al.
Neuroscience Letters|October 1, 2013
Effects of fumaric acid esters on blood-brain barrier tight junction proteinsKarelle Bénardais, Refik Pul, Vikramjeet Singh, et al.
Annals of Surgery|September 1, 1985
The role of splenectomy in multimodality treatment of thrombotic thrombocytopenic purpuraP A Schneider, A A Rayner, C A Linker, et al.
Archives of Neurology|March 14, 2002
Association of a null mutation in the CNTF gene with early onset of multiple sclerosisRalf Giess, Mathias Mäurer, Ralf Linker, et al.
Journal of the American Chemical Society|November 4, 2008
Remarkable oxidation stability of glycals: excellent substrates for cerium(IV)-mediated radical reactionsTorsten Linker, Dirk Schanzenbach, Elangovan Elamparuthi, et al.
Bone Marrow Transplantation|March 18, 2009
Auto-SCT for AML in second remission: CALGB study 9620C A Linker, K Owzar, B Powell, et al.
Nature Communications|January 18, 2020
Microglial activation increases cocaine self-administration following adolescent nicotine exposureK E Linker, M Gad, P Tawadrous, et al.
Frontiers in Neurology|July 14, 2022
OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in GermanyTjalf Ziemssen, Stephan Richter, Mathias Mäurer, et al.
Neurogenetics|February 12, 2016
Multiple sclerosis in families: risk factors beyond known genetic polymorphismsDenis A Akkad, De-Hyung Lee, Kathrin Bruch, et al.
Experimental Neurology|March 16, 2016
High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cellsStefanie Jörg, Jan Kissel, Arndt Manzel, et al.
Pageof 86

Showing results (481-490 of 860) with videos related to

Sort By:
Pageof 86
Frontiers in Neurology|August 6, 2021
Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander?Andrea Wagner, Jonas Maderer, Sibylle Wilfling, et al.
Neuroscience Letters|October 1, 2013
Effects of fumaric acid esters on blood-brain barrier tight junction proteinsKarelle Bénardais, Refik Pul, Vikramjeet Singh, et al.
Annals of Surgery|September 1, 1985
The role of splenectomy in multimodality treatment of thrombotic thrombocytopenic purpuraP A Schneider, A A Rayner, C A Linker, et al.
Archives of Neurology|March 14, 2002
Association of a null mutation in the CNTF gene with early onset of multiple sclerosisRalf Giess, Mathias Mäurer, Ralf Linker, et al.
Journal of the American Chemical Society|November 4, 2008
Remarkable oxidation stability of glycals: excellent substrates for cerium(IV)-mediated radical reactionsTorsten Linker, Dirk Schanzenbach, Elangovan Elamparuthi, et al.
Bone Marrow Transplantation|March 18, 2009
Auto-SCT for AML in second remission: CALGB study 9620C A Linker, K Owzar, B Powell, et al.
Nature Communications|January 18, 2020
Microglial activation increases cocaine self-administration following adolescent nicotine exposureK E Linker, M Gad, P Tawadrous, et al.
Frontiers in Neurology|July 14, 2022
OzEAN Study to Collect Real-World Evidence of Persistent Use, Effectiveness, and Safety of Ozanimod Over 5 Years in Patients With Relapsing-Remitting Multiple Sclerosis in GermanyTjalf Ziemssen, Stephan Richter, Mathias Mäurer, et al.
Neurogenetics|February 12, 2016
Multiple sclerosis in families: risk factors beyond known genetic polymorphismsDenis A Akkad, De-Hyung Lee, Kathrin Bruch, et al.
Experimental Neurology|March 16, 2016
High salt drives Th17 responses in experimental autoimmune encephalomyelitis without impacting myeloid dendritic cellsStefanie Jörg, Jan Kissel, Arndt Manzel, et al.
Pageof 86